In this online CME self-learning activity:
According to the CDC, there are more than 1.1 million people aged thirteen and older living with HIV (PLWH). Since the beginning of the HIV epidemic in the 1980s, advances in public health initiatives and treatments have considerably lengthened the life expectancy of PLWH, and as they have begun to live longer, the number of patients with chronic HIV infection has greatly increased. What was once acute inpatient care of the dying has become outpatient chronic disease management with an emphasis on a long-term balancing act that involves the consideration of comorbidities, drug interactions, and adverse drug events in an aging HIV population.
Projections suggest that there may soon be a shortage of HIV providers. To avoid the imminent shortfall of HIV specialists, PCPs to manage HIV infection, comorbidities, and sequelae is critical to meeting the demand for HIV care. The quality of HIV care experienced PCPs provide is substantially similar to that of infectious disease specialists, but research shows that nearly 40% of PCPs and residents do not feel comfortable providing comprehensive services for PLWH in all disease stages.
HCPs specializing in: Infectious diseases, HIV, and internal medicine; physician assistants, nurse practitioners, and pharmacists who practice in infectious disease; and any other healthcare professionals with an interest in or who clinically encounter patients with HIV.
Commercial Support Disclosure: This activity is supported by educational grants from Merck and Gilead.
Learners may participate in this activity free of charge.
Release Date: August 02, 2020 -- Expiration Date: August 02, 2022
Faculty: David Cennimo, MD
Epidemiology of and risk factors for HIV
Recent HIV guideline updates
Treatment of HIV/AIDS
Barriers to optimal care in patients with HIV
Summary, conclusions, and best practice recap
By the end of the session the participant will be able to:
ACCME Activity #201861261ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: David J. Cennimo, MD, FACP, FAAP, FIDSA, AAHIVM, Assistant Professor of Medicine and Pediatrics, Rutgers New Jersey Medical School, has no relevant conflicts of interest to disclose.
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, CEO of ScientiaCME, has no relevant conflicts of interest to disclose.
Commercial Support Disclosure: This activity is supported by an educational grant from Gilead and Merck.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.